Y Intercept (Hong Kong) LTD Vanda Pharmaceuticals Inc. Transaction History

Y Intercept (Hong Kong) LTD

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$3.91 - $6.5 $41,422 - $68,861	10,594 New	10,594 $59,000
Q3 2023 Nov 14, 2023	BUY	$4.28 - $6.57 $695,393 - $1.07 Million	162,475 New	162,475 $701,000
Q1 2023 May 09, 2023	SELL	$6.18 - $7.99 $94,788 - $122,550	-15,338 Reduced 26.41%	42,743 $290,000
Q4 2022 Feb 14, 2023	BUY	$6.87 - $10.96 $399,016 - $636,567	58,081 New	58,081 $429,000

161

45.2M

165K

33.6K

Ticker VNDA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,561,500
Market Cap $247M
Description
Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company's marketed products include HETLIOZ for the treatment of non-24-hour sleep-wake disorders; and Fanapt oral tablets for the treatment of schizophrenia. Its products under developme...

Get notified when there are updates to the investment portfolio of Y Intercept (Hong Kong) LTD, based on Form 13F filings with the SEC.

Stay updated on Y Intercept (Hong Kong) LTD with notifications on news.